Utah Admin. Code 501-21-5

Current through Bulletin No. 2024-21, November 1, 2024
Section R501-21-5 - Substance Use Disorder Treatment Programs
(1) Each substance use disorder treatment program shall:
(a) develop and implement a plan on how to support opioid overdose reversal;
(b) maintain proof of completion of the National Survey of Substance Abuse Treatment Services annually; and
(c) ensure medical cannabis is not an enticement or offered, referred, or recommended as treatment for substance use disorder.
(2) A program providing medication for opioid use disorder (MOUD) shall:
(a) maintain a program-wide counselor to client ratio of: 1:65 to provide adequate substance use counseling to each client as clinically necessary; and
(b) assure each client sees a licensed practitioner that may prescribe controlled substances at least once yearly.
(3) Each MOUD provider that prescribes, administers or dispenses methadone shall:
(a) admit a client to the program only after the completion of a face-to-face visit with a licensed practitioner authorized to prescribe controlled substances who confirms opioid dependence;
(b) ensure that a licensed practitioner authorized to prescribe controlled substances approves every subsequent dose increase before the change;
(c) require each client admitted to the program to participate in random drug testing performed randomly at least eight times per year, per patient in maintenance treatment, in accordance with generally accepted clinical practice and in accordance with 42CFR part 8; and
(d) require one hour of prescribing practitioner time at the program site each month for every ten MOUD clients enrolled.
(4) Each MOUD program that prescribes, administers or dispenses methadone shall:
(a) maintain Substance Abuse and Mental Health Services Administration certification and accreditation as an opioid treatment program;
(b) employ the following:
(i) a licensed physician who is an ASAM-certified physician;
(ii) a prescribing licensed practitioner who can document specific training in current industry standards regarding methadone treatment for opioid addictions; or
(iii) a prescribing licensed practitioner who can document specific training or experience in methadone treatment for opioid addictions; and
(c) provide one qualified provider as defined in Section 58-17b-309.7 to dispense or administer medications for every 150 methadone clients dosing on an average daily basis.
(5) An outpatient treatment program may offer mobile MOUD services under their physical site license if:
(a) the existing licensed site provides MOUD services;
(b) the licensee maintains policy and procedures addressing the agency policies as they apply to the mobile unit; and
(c) registration requirements of the Drug Enforcement Administration Code of Federal Regulations, Title 21, Parts 1300, 1301 and 1304, 2021 edition are met.
(6) An alcohol and drug education provider shall provide court ordered education only if certified to do so through the OSUMH in accordance with Rule R523-11.
(7) A licensed substance use disorder counselor (SUDC) in a substance use disorder outpatient treatment program may:
(a) collect client information;
(b) conduct the screening portion of an assessment;
(c) make level of care recommendations; and
(d) identify a substance use disorder.
(8) A SUDC may not diagnose a client.
(9) A OSUMH certified alcohol and drug education provider shall:
(a) complete and maintain a substance use screening, that may be shared between providers with written client consent, for each client before providing the education course;
(b) provide a workbook to each participant to keep upon completion of the course;
(c) ensure at least 16 hours of course education; and
(d) provide separate classes for adults and youth.
(10) A provider offering services to justice-involved clients shall:
(a) operate in compliance with Rules R523-3 and R523-4;
(b) maintain a validated criminogenic screen or risk assessment for each justice-involved client that is conducted with an accepted tool including:
(i) Level of Service Inventory-Revised (LSI-R);
(ii) Risk and Needs Triage (RANT);
(iii) Ohio Risk Assessment System (ORAS): or
(iv) any other screen that the provider can demonstrate their validation to the OSUMH:
(c) separate clients into treatment groups according to level of risk assessed;
(d) complete screenings that assess both substance abuse and mental health comorbidity; and
(e) treat, or refer to other licensed Department of Health and Human Services programs that serve justice-involved clients to treat the array of disorders noted in the screening.

Utah Admin. Code R501-21-5

Amended by Utah State Bulletin Number 2014-23, effective 11/3/2014
Amended by Utah State Bulletin Number 2017-8, effective 3/24/2017
Amended by Utah State Bulletin Number 2019-5, effective 2/12/2019
Amended by Utah State Bulletin Number 2024-03, effective 1/22/2024